# Argatroban Plus R-tPA for Acute Ischemic Stroke

> **NCT03740958** · PHASE4 · COMPLETED · sponsor: **General Hospital of Shenyang Military Region** · enrollment: 808 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** rt-PA
- **DRUG:** Argatroban

## Key facts

- **NCT ID:** NCT03740958
- **Lead sponsor:** General Hospital of Shenyang Military Region
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-21
- **Primary completion:** 2022-01-30
- **Final completion:** 2022-01-30
- **Target enrollment:** 808 (ACTUAL)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03740958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03740958, "Argatroban Plus R-tPA for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03740958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*